Skip to main content
  • AACR Journals
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Molecular Targets Collections
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Journals
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Molecular Targets Collections
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
Molecular Medicine in Practice

Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer

Marianne K. Melnik, Craig P. Webb, Patrick J. Richardson, Charles R. Luttenton, Alan D. Campbell, Thomas J. Monroe, Timothy J. O'Rourke, Kathleen J. Yost, Connie M. Szczepanek, Michelle R. Bassett, Kimberly J. Truszkowski, Phyllis Stein, Matthew W. Van Brocklin, Alan T. Davis, Gabriela Bedolla, George F. Vande Woude and Han-Mo Koo
Marianne K. Melnik
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Craig P. Webb
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick J. Richardson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles R. Luttenton
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan D. Campbell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas J. Monroe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothy J. O'Rourke
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathleen J. Yost
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Connie M. Szczepanek
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michelle R. Bassett
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kimberly J. Truszkowski
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Phyllis Stein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew W. Van Brocklin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan T. Davis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabriela Bedolla
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George F. Vande Woude
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Han-Mo Koo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1535-7163.MCT-09-0854
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Additional Files

  • Supplementary Data, Melnik, et al.

    Files in this Data Supplement:

    • Supplementary Table 1
    • Supplementary Form 1
Next
Back to top

Published OnlineFirst August 3, 2010
doi: 10.1158/1535-7163.MCT-09-0854

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer
(Your Name) has forwarded a page to you from Molecular Cancer Therapeutics
(Your Name) thought you would be interested in this article in Molecular Cancer Therapeutics.
Citation Tools
Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer
Marianne K. Melnik, Craig P. Webb, Patrick J. Richardson, Charles R. Luttenton, Alan D. Campbell, Thomas J. Monroe, Timothy J. O'Rourke, Kathleen J. Yost, Connie M. Szczepanek, Michelle R. Bassett, Kimberly J. Truszkowski, Phyllis Stein, Matthew W. Van Brocklin, Alan T. Davis, Gabriela Bedolla, George F. Vande Woude and Han-Mo Koo
Mol Cancer Ther August 3 2010 DOI: 10.1158/1535-7163.MCT-09-0854

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer
Marianne K. Melnik, Craig P. Webb, Patrick J. Richardson, Charles R. Luttenton, Alan D. Campbell, Thomas J. Monroe, Timothy J. O'Rourke, Kathleen J. Yost, Connie M. Szczepanek, Michelle R. Bassett, Kimberly J. Truszkowski, Phyllis Stein, Matthew W. Van Brocklin, Alan T. Davis, Gabriela Bedolla, George F. Vande Woude and Han-Mo Koo
Mol Cancer Ther August 3 2010 DOI: 10.1158/1535-7163.MCT-09-0854
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • EMT and CSCs in HER2+ Breast Cancer
  • Methylglyoxal Enhances TRAIL Efficacy
  • Sorafenib Induces Reactive Oxygen Species Production
Show more Molecular Medicine in Practice
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright 2016 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement